The Invesco Perpetual Monthly Income Plus Fund aims to achieve a high level of income whilst seeking to maximise total return through investing in high yielding corporate and Government bonds, together with UK equities.
Name | % Net Assets |
---|---|
AstraZeneca | 6.2% |
UK Treasury | 3.1% |
Linde 8.125% £ Bonds 14/7/2016 | 2.6% |
SLM 5.375% £ Bonds 15/12/2010 | 2.6% |
UPC | 2.4% |
Rhodia € FRN 15/10/2013 | 1.1% |
Rexam 6.75% € Bonds 29/6/2017 | 1.1% |
BG | 1.0% |
Intergen 9.5% £ Bonds 30/6/2017 | 1.0% |
Reynolds American | 1.0% |
Key | % Net Assets |
---|---|
AstraZeneca | 6.2% |
UK Treasury | 3.1% |
Linde 8.125% £ Bonds 14/7/2016 | 2.6% |
SLM 5.375% £ Bonds 15/12/2010 | 2.6% |
Other | 85.5% |
Date | 21-Nov-2024 |
---|---|
NAV | 94.28p |
Currency | GBP |
Change | -0.070p |
% | -0.07% |
YTD change | -0.080p |
YTD % | -0.08% |
Fund Inception | 06/02/1999 |
---|---|
Fund Manager | Paul Causer / Paul Read / Neil Woodford |
TER | 1.44 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | £100 |
Savings | £20 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.42% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.00 |
Sharpe ratio | 0.53 |
You are here: research